HR+, HER2- breast cancer at high risk of recurrence research hub

DOSABEMA-Pharmacokinetic model of abemaciclib: correlation with severe diarrhea as the primary toxicity endpoint in patients with hormone receptor-positive localized breast cancer

This study looks at how a breast cancer drug, Verzenios, affects people's bodies and how this links to side effects like severe diarrhoea. It focuses on women with a specific type of breast cancer to understand the drug better and make treatment safer.